US Patent 7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Patent 7566719 was granted and assigned to Enanta Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

July 28, 2009

Patent Application Number

12043421

Date Filed

March 6, 2008

Patent Primary Examiner

Patent abstract

The present invention relates to compounds of Formula I or II, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.